Phase I/II Study of QEL-005 in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) and in Patients With Difficult to Treat Rheumatoid Arthritis (D2TRA).
NCT07473154 · NOT YET RECRUITING · Phase 2
ReadTheTrial indexes 1 studies for Diffuse Cutaneous Systemic Sclerosis. The most common development stage is Phase 2 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Diffuse Cutaneous Systemic Sclerosis.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 1 | 100% |
There are 1 clinical trials listed for Diffuse Cutaneous Systemic Sclerosis. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Diffuse Cutaneous Systemic Sclerosis trials are distributed across: Phase 2 (1).